These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 16275825)

  • 1. Statins and cognitive function in the elderly: the Cardiovascular Health Study.
    Bernick C; Katz R; Smith NL; Rapp S; Bhadelia R; Carlson M; Kuller L;
    Neurology; 2005 Nov; 65(9):1388-94. PubMed ID: 16275825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial.
    Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J
    Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR; Gandhi S; Blasetto J; Heien H; Sasane R; Nelson SP
    Am J Geriatr Pharmacother; 2007 Sep; 5(3):185-94. PubMed ID: 17996658
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statins in ischemic stroke: just low-density lipoprotein lowering or more?
    Stead LG; Vaidyanathan L; Kumar G; Bellolio MF; Brown RD; Suravaram S; Enduri S; Gilmore RM; Decker WW
    J Stroke Cerebrovasc Dis; 2009; 18(2):124-7. PubMed ID: 19251188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. APOE genotype, cholesterol level, lipid-lowering treatment, and dementia: the Three-City Study.
    Dufouil C; Richard F; Fiévet N; Dartigues JF; Ritchie K; Tzourio C; Amouyel P; Alpérovitch A
    Neurology; 2005 May; 64(9):1531-8. PubMed ID: 15883313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do statins reduce risk of incident dementia and Alzheimer disease? The Cache County Study.
    Zandi PP; Sparks DL; Khachaturian AS; Tschanz J; Norton M; Steinberg M; Welsh-Bohmer KA; Breitner JC;
    Arch Gen Psychiatry; 2005 Feb; 62(2):217-24. PubMed ID: 15699299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Education, atrophy, and cognitive change in an epidemiological sample in early old age.
    Christensen H; Batterham PJ; Mackinnon AJ; Anstey KJ; Wen W; Sachdev PS
    Am J Geriatr Psychiatry; 2009 Mar; 17(3):218-26. PubMed ID: 19454848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association between different lipid-lowering treatment strategies and blood pressure control in the Brisighella Heart Study.
    Borghi C; Dormi A; Veronesi M; Sangiorgi Z; Gaddi A;
    Am Heart J; 2004 Aug; 148(2):285-92. PubMed ID: 15308998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and the risk of incident dementia: the Cardiovascular Health Study.
    Rea TD; Breitner JC; Psaty BM; Fitzpatrick AL; Lopez OL; Newman AB; Hazzard WR; Zandi PP; Burke GL; Lyketsos CG; Bernick C; Kuller LH
    Arch Neurol; 2005 Jul; 62(7):1047-51. PubMed ID: 16009757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cerebral small-vessel disease and decline in information processing speed, executive function and memory.
    Prins ND; van Dijk EJ; den Heijer T; Vermeer SE; Jolles J; Koudstaal PJ; Hofman A; Breteler MM
    Brain; 2005 Sep; 128(Pt 9):2034-41. PubMed ID: 15947059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of rosuvastatin compared with other statins on lipid levels and National Cholesterol Education Program goal attainment for low-density lipoprotein cholesterol in a usual care setting.
    Bullano MF; Wertz DA; Yang GW; Kamat S; Borok GM; Gandhi S; McDonough KL; Willey VJ
    Pharmacotherapy; 2006 Apr; 26(4):469-78. PubMed ID: 16553504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apolipoprotein E genotypes are associated with lipid-lowering responses to statin treatment in diabetes: a Go-DARTS study.
    Donnelly LA; Palmer CN; Whitley AL; Lang CC; Doney AS; Morris AD; Donnan PT
    Pharmacogenet Genomics; 2008 Apr; 18(4):279-87. PubMed ID: 18334912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study.
    Atthobari J; Brantsma AH; Gansevoort RT; Visser ST; Asselbergs FW; van Gilst WH; de Jong PE; de Jong-van den Berg LT;
    Nephrol Dial Transplant; 2006 Nov; 21(11):3106-14. PubMed ID: 16720593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Test-retest reliable coefficients and 5-year change scores for the MMSE and 3MS.
    Tombaugh TN
    Arch Clin Neuropsychol; 2005 Jun; 20(4):485-503. PubMed ID: 15896562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Statins and cognitive functioning in the elderly: a population-based study.
    Benito-León J; Louis ED; Vega S; Bermejo-Pareja F
    J Alzheimers Dis; 2010; 21(1):95-102. PubMed ID: 20413854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A paucimorphic variant in the HMG-CoA reductase gene is associated with lipid-lowering response to statin treatment in diabetes: a GoDARTS study.
    Donnelly LA; Doney AS; Dannfald J; Whitley AL; Lang CC; Morris AD; Donnan PT; Palmer CN
    Pharmacogenet Genomics; 2008 Dec; 18(12):1021-6. PubMed ID: 18815589
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Cognitive enhancement effect of piracetam in patients with mild cognitive impairment and dementia].
    Tariska P; Paksy A
    Orv Hetil; 2000 May; 141(22):1189-93. PubMed ID: 10853348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Education and the cognitive decline associated with MRI-defined brain infarct.
    Elkins JS; Longstreth WT; Manolio TA; Newman AB; Bhadelia RA; Johnston SC
    Neurology; 2006 Aug; 67(3):435-40. PubMed ID: 16894104
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents.
    Dupuy AM; Carrière I; Scali J; Cristol JP; Ritchie K; Dartigues JF; Gambert P; Ancelin ML
    Climacteric; 2008 Feb; 11(1):74-83. PubMed ID: 18202967
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance.
    Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S
    Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.